Last reviewed · How we verify

NCT04988594

Effects of Yogurt With Probiotics in Adults With Type 2 Diabetes Mellitus

Completed NA Last updated 3 August 2021
What this trial tests

NA trial testing Lactobacillus acidophilus 207, Bifidobacterium lactis B420/205 in Type2 Diabetes in 46 participants. Completed in 30 April 2021.

Timeline
1 February 2021
Primary endpoint
30 April 2021
30 April 2021

Quick facts

Lead sponsorFaculty of Medical Sciences, Clinical Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposehealth services research
Enrollment46
Start date1 February 2021
Primary completion30 April 2021
Estimated completion30 April 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Faculty of Medical Sciences, Clinical Hospital

Who can join

Adults 25 to 65, any sex, with Type2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to analyze the effects of the consumption of yogurt with concentrated and lyophilized probiotic cultures on the parameters associated with glucose homeostasis, inflammation and oxidative stress in patients with Type 2 Diabetes Mellitus (T2DM).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Gut microbiota in the pathogenesis and therapeutic approaches of diabetes.
    Crudele L, Gadaleta RM, Cariello M, Moschetta A. · · 2023 · cited 147× · PMID 37804567 · DOI 10.1016/j.ebiom.2023.104821

Verify or expand the search:

Other recruiting trials for Type2 Diabetes

Currently open trials in the same condition.

Other Faculty of Medical Sciences, Clinical Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04988594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing